Apollo Care SEMAGLUTIDE 9mg Vial Recall: Particulate Matter Hazard
Apollo Care recalls SEMAGLUTIDE 9mg vials due to particulate matter that could cause injection site reactions. Affected vials have specific NDC and lot numbers. Consumers should contact Apollo Care for details.
Lower-risk recall
Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
What happened, in plain English
Apollo Care is recalling SEMAGLUTIDE 9mg (4.5 mg/mL) vials that may contain particulate matter. This could lead to injection site reactions or other issues if used. The recall affects specific lot numbers and expiration dates. Read more at govinfonow.com/recall/454415-apollo-care-semaglutide-9mg-vial-recall-particulate-matter-hazard.
Source Summary by GovInfoNow · govinfonow.com/recall/454415-apollo-care-semaglutide-9mg-vial-recall-particulate-matter-hazard · Updated August 27, 2026 · FDA enforcement record: FDA #D-0751-2026
Cite this page
“Apollo Care SEMAGLUTIDE 9mg Vial Recall: Particulate Matter Hazard.” GovInfoNow, updated August 27, 2026. https://govinfonow.com/recall/454415-apollo-care-semaglutide-9mg-vial-recall-particulate-matter-hazard. Based on FDA recall #D-0751-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0751-2026%22&limit=1).
Why it’s dangerous
The vials may contain small particles of nylon/polyamide and silk/proteinaceous material. These particles could cause irritation or reactions at the injection site when used.
Who’s affected
People with prescriptions for SEMAGLUTIDE 9mg vials from Apollo Care. Those who have the specific lot numbers listed in the recall are most at risk.
How to tell if you have this one
Check for NDC 71170-822-02 with lot numbers AC-017125, AC-017138, AC-017147, AC-017214, AC-017226, or AC-017228. The vials expire by 8/30/2026 or 12/31/2026.
- Brand
Apollo Care- Category
Drug
All 11 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
- Classification
Class II- Status
Ongoing- Distribution
Nationwide within the U.S
| Recall number | Product, codes & lots | Quantity |
|---|---|---|
| D-0747-2026 | SEMAGLUTIDE 12.5MG (2.5MG/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-495-05; Lot: AC-017108, Exp. 11/17/2026; AC-017110, Exp. 11/20/2026; AC-017112, Exp. 11/21/2026; AC-017142, AC-017144, Exp. 12/10/2026; AC-017166, AC-017167, AC-017177, AC-017213, AC-017224, AC-017225, Exp. 12/31/2026 | 56,918 vials. |
| D-0748-2026 | SEMAGLUTIDE 2.25MG (0.9 mg/mL), 2.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202 NDC 71170-811-02; Lot: AC-017114, Exp. 11/24/2026; AC-017164, AC-017204, AC-017205, Exp. 12/31/2026. | 23,029 vials. |
| D-0749-2026 | SEMAGLUTIDE 6.75mg (4.5 mg/mL), 1.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202 NDC 71170-821-01; Lot: C-017115, Exp. 11/25/2026; AC-017163, Exp. 12/31/2026; AC-017169, AC-017170, AC-017171, Exp. 12/31/2026; AC-017230, AC-017231, Exp. 5/5/2027. | 37,546 vials. |
| D-0750-2026 | SEMAGLUTIDE 4.5mg (0.9 mg/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-812-03; Lot: AC-017124, Exp. 8/30/2026; AC-017136, Exp. 12/31/2026. | 9,762 vials. |
| D-0751-2026 | SEMAGLUTIDE 9mg (4.5 mg/mL), 2 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-822-02; Lot: AC-017125, Exp. 8/30/2026; AC-017138, AC-017147, AC-017214, AC-017226, AC-017228, Exp. 12/31/2026. | 24,608 vials. |
| D-0752-2026 | SEMAGLUTIDE 0.9mg (0.9 mg/mL), 1 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-810-01; Lot: AC-017131, Exp. 8/30/2026. | 4,748 vials. |
| D-0753-2026 | SEMAGLUTIDE 2.5mg (1mg/mL), Glycine 12.5 mg (5mg/mL), 2.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-711-02; Lot: AC-017271, Exp. 12/12/2026. | 250 vials. |
| D-0754-2026 | SEMAGLUTIDE 5mg (1mg/mL), Glycine 25 mg (5mg/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202.NDC 71170-712-03; Lot: AC-017272, Exp. 12/12/2026. | 250 vials. |
| D-0755-2026 | SEMAGLUTIDE 7.5mg (5mg/mL), Glycine 7.5 mg (5mg/mL), 1.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-721-01; Lot: AC-017273, Exp. 12/12/2026. | 250 vials. |
| D-0756-2026 | SEMAGLUTIDE 10mg (5mg/mL), Glycine 10 mg (5mg/mL), 2 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-722-02; Lot: AC-017274, Exp. 12/12/2026. | 500 vials. |
| D-0757-2026 | SEMAGLUTIDE 20mg (5mg/mL), Glycine 20 mg (5mg/mL), 4 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-724-04.; Lot: AC-017275, Exp. 12/13/2026; AC-017282, AC-017285, Exp. 12/27/2026. | 4,250 vials. |
What to do — step by step
Check Vial Details
Look for NDC 71170-822-02 and specific lot numbers listed in the recall.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide within the U.S” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 21 days after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- Added to GovInfoNow
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0751-2026 (July 29, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0751-2026 to see it in context.
- Plain-language summary written by qwen3:4b on August 27, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.